Originally published by Globalresearch.ca.
The UK’s Medicines and Healthcare products Regulatory Agency, or MHRA, is meant to be a neutral body that is responsible for making sure that the medicine and medical devices used in the country are acceptably safe.
However, there are serious questions about the agency’s impartiality because they receive significant funding from the Bill & Melinda Gates Foundation in what can only be considered a major conflict of interest. The foundation holds major shares in COVID-19 vaccine developers Pfizer and BioNTech.
Perhaps this explains why the Pfizer and BioNTech vaccine was the first one to be authorized for use in children aged 12 and over back in June and remained the only one available to this age group until Moderna’s vaccine was approved this week.
The approval of Pfizer’s vaccine was particularly shocking when you consider that 86 percent of children who participated in the very short and small clinical study used to make the decision suffered from an adverse reaction.
In a Freedom of Information request posted on the website of the MHRA, a representative of the agency admitted that they do receive funding from the Bill and Melinda Gates Foundation that mainly supports work on strengthening the regulatory systems in other countries. They added that most of their income comes from fees paid by the pharmaceutical industry.
This is an excerpt of the original post published at Bigpharmanews.com.
This post was republished by Globalresearch.ca.
The Centre for Research on Globalization (CRG) is an independent research and media organization based in Montreal. The CRG is a registered non-profit organization in the province of Quebec, Canada.